Here’s your cancer news round up this weekend. Happy reading.
News from the survivors
Armstrong’s stolen bike recovered
Testicular cancer survivor Lance Armstrong is back on his bike pedaling at the Amgen Tour of California. Earlier this week, someone stole his one-of-a-kind legendary bike but he’s got it back now, according to major news channels. Armstrong is currently in 4th place. He is a strong advocate of cancer research and is the founder of the Lance Armstrong Foundation. Check out (see video) one of his Nike commercials that also feature children cancer patients.
News from the drug regulators
Cytokine Therapies: Novel Approaches for Clinical Indications
This two-day public forum presented by the US FDA and the New York Academy of Sciences “will focus on the clinical use of cytokines and cytokines antagonists as therapeutic agents for the treatment of human diseases, including cancer and autoimmune disorders such as rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.” Mar 26, 2009 – Mar 27, 2009 at 8:00 AM – 6:00 PM, The New York Academy of Sciences, 7 World Trade Center.
News from the patients
What’s in a name? For patients, a piece of history
If you stand on the Pan-Massachusetts Challenge Bridge and look at the metal beams forming the shell of the currently constructed Yawkey Center for Cancer Care (YCCC), you’d see names spray painted on them. But they are not the works of vandals. The ironworkers sprayed them themselves in honor of the pediatric cnacer patients at the Center. “The state-of-the-art outpatient care and clinical research facility currently being built on Dana-Farber’s Longwood campus.”
Web portal project for drug research information gets data boost
Now, this is a useful tool for researchers and health professionals. The public gets to know about drugs which have been approved. But what about those which haven’t been approved but could still have the potential to cure? It may be that what doesn’t work for one disease may work for another. And all that money and time spent on the development of these drugs would be such a waste. In this new web portal Pharmaceutical Assets Portal developed by an academic consortium led by the University of California at Davis, researchers can get access to data on unapproved but potentially useful drugs. The portal “will allow scientists to learn about existing drugs that could be used as cures for diseases and conditions other than the one they were originally intended to target. It is a process known as drug repositioning or repurposing.”